Testicular cancer: When less is more

Lance C. Pagliaro

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Clinical stage I testicular cancer is highly curable. The treatment options include adjuvant chemotherapy or surveillance for most patients, radiotherapy for seminoma, and retroperitoneal lymph node dissection for selected patients with nonseminomatous germ cell tumors. This review discusses the decision points with emphasis on the advantages and disadvantages of each management option.

Original languageEnglish (US)
Pages (from-to)271-277
Number of pages7
JournalCurrent Oncology Reports
Volume12
Issue number4
DOIs
StatePublished - Jul 2010
Externally publishedYes

Fingerprint

Testicular Neoplasms
Seminoma
Adjuvant Chemotherapy
Lymph Node Excision
Radiotherapy
Therapeutics
Nonseminomatous germ cell tumor

Keywords

  • Carboplatin
  • Cisplatin
  • Embryonal carcinoma
  • Male infertility
  • Orchiectomy
  • Radiotherapy
  • Seminoma
  • Teratoma
  • Testicular neoplasm
  • Treatment-related malignancy

ASJC Scopus subject areas

  • Oncology

Cite this

Testicular cancer : When less is more. / Pagliaro, Lance C.

In: Current Oncology Reports, Vol. 12, No. 4, 07.2010, p. 271-277.

Research output: Contribution to journalReview article

Pagliaro, Lance C. / Testicular cancer : When less is more. In: Current Oncology Reports. 2010 ; Vol. 12, No. 4. pp. 271-277.
@article{29dcc1f5d8204fe7bc814508707d85ee,
title = "Testicular cancer: When less is more",
abstract = "Clinical stage I testicular cancer is highly curable. The treatment options include adjuvant chemotherapy or surveillance for most patients, radiotherapy for seminoma, and retroperitoneal lymph node dissection for selected patients with nonseminomatous germ cell tumors. This review discusses the decision points with emphasis on the advantages and disadvantages of each management option.",
keywords = "Carboplatin, Cisplatin, Embryonal carcinoma, Male infertility, Orchiectomy, Radiotherapy, Seminoma, Teratoma, Testicular neoplasm, Treatment-related malignancy",
author = "Pagliaro, {Lance C.}",
year = "2010",
month = "7",
doi = "10.1007/s11912-010-0105-4",
language = "English (US)",
volume = "12",
pages = "271--277",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - Testicular cancer

T2 - When less is more

AU - Pagliaro, Lance C.

PY - 2010/7

Y1 - 2010/7

N2 - Clinical stage I testicular cancer is highly curable. The treatment options include adjuvant chemotherapy or surveillance for most patients, radiotherapy for seminoma, and retroperitoneal lymph node dissection for selected patients with nonseminomatous germ cell tumors. This review discusses the decision points with emphasis on the advantages and disadvantages of each management option.

AB - Clinical stage I testicular cancer is highly curable. The treatment options include adjuvant chemotherapy or surveillance for most patients, radiotherapy for seminoma, and retroperitoneal lymph node dissection for selected patients with nonseminomatous germ cell tumors. This review discusses the decision points with emphasis on the advantages and disadvantages of each management option.

KW - Carboplatin

KW - Cisplatin

KW - Embryonal carcinoma

KW - Male infertility

KW - Orchiectomy

KW - Radiotherapy

KW - Seminoma

KW - Teratoma

KW - Testicular neoplasm

KW - Treatment-related malignancy

UR - http://www.scopus.com/inward/record.url?scp=77956445326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956445326&partnerID=8YFLogxK

U2 - 10.1007/s11912-010-0105-4

DO - 10.1007/s11912-010-0105-4

M3 - Review article

C2 - 20443156

AN - SCOPUS:77956445326

VL - 12

SP - 271

EP - 277

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 4

ER -